CNBX Pharmaceuticals Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
CNBX Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2010 to Q4 2024.
  • CNBX Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending November 30, 2024 was -$34.4K, a 80.8% increase year-over-year.
  • CNBX Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending November 30, 2024 was -$551K, a 84.4% increase year-over-year.
  • CNBX Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$695K, a 81.3% increase from 2023.
  • CNBX Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.71M, a 0.35% increase from 2022.
  • CNBX Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.72M, a 16.6% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$551K -$34.4K +$144K +80.8% Sep 1, 2024 Nov 30, 2024 10-Q 2025-01-13
Q3 2024 -$695K -$60.6K +$513K +89.4% Jun 1, 2024 Aug 31, 2024 10-K 2024-11-29
Q2 2024 -$1.21M -$131K +$24.1K +15.6% Mar 1, 2024 May 31, 2024 10-Q 2024-07-15
Q1 2024 -$1.23M -$325K +$2.3M +87.6% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-16
Q4 2023 -$3.53M -$179K +$179K +50.1% Sep 1, 2023 Nov 30, 2023 10-Q 2025-01-13
Q3 2023 -$3.71M -$574K -$93.8K -19.6% Jun 1, 2023 Aug 31, 2023 10-K 2024-11-29
Q2 2023 -$3.62M -$155K +$527K +77.3% Mar 1, 2023 May 31, 2023 10-Q 2024-07-15
Q1 2023 -$4.14M -$2.62M -$1.39M -112% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-16
Q4 2022 -$2.76M -$358K +$965K +73% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-12
Q3 2022 -$3.72M -$480K +$201K +29.6% Jun 1, 2022 Aug 31, 2022 10-K 2023-11-30
Q2 2022 -$3.92M -$682K +$642K +48.5% Mar 1, 2022 May 31, 2022 10-Q 2023-07-14
Q1 2022 -$4.57M -$1.24M -$704K -132% Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-14
Q4 2021 -$3.86M -$1.32M -$668K -102% Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-13
Q3 2021 -$3.19M -$681K +$50.6K +6.91% Jun 1, 2021 Aug 31, 2021 10-K 2022-11-30
Q2 2021 -$3.25M -$1.32M -$598K -82.4% Mar 1, 2021 May 31, 2021 10-Q 2022-07-14
Q1 2021 -$2.65M -$535K +$333K +38.4% Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-12
Q4 2020 -$2.98M -$655K +$4.49M +87.3% Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-13
Q3 2020 -$7.47M -$732K +$662K +47.5% Jun 1, 2020 Aug 31, 2020 10-K 2021-11-29
Q2 2020 -$8.13M -$726K -$178K -32.6% Mar 1, 2020 May 31, 2020 10-Q 2021-07-14
Q1 2020 -$7.95M -$868K -$4.6M -123% Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-14
Q4 2019 -$3.35M -$5.14M -$4.49M -684% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-14
Q3 2019 $1.13M -$1.39M -$661K -90.3% Jun 1, 2019 Aug 31, 2019 10-K 2020-11-04
Q2 2019 $1.79M -$547K +$324K +37.2% Mar 1, 2019 May 31, 2019 10-Q 2020-07-14
Q1 2019 $1.47M $3.73M +$5.36M Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-13
Q4 2018 -$3.9M -$656K -$118K -22% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-14
Q3 2018 -$3.78M -$732K +$371K +33.6% Jun 1, 2018 Aug 31, 2018 10-K 2019-11-29
Q2 2018 -$4.15M -$872K -$626K -255% Mar 1, 2018 May 31, 2018 10-Q 2019-07-15
Q1 2018 -$3.52M -$1.64M -$1.2M -273% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-15
Q4 2017 -$2.32M -$538K -$390K -266% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-17
Q3 2017 -$1.93M -$1.1M -$1.02M -1305% Jun 1, 2017 Aug 31, 2017 10-K 2018-11-29
Q2 2017 -$909K -$245K -$219K -827% Mar 1, 2017 May 31, 2017 10-Q 2018-07-16
Q1 2017 -$690K -$438K -$291K -198% Dec 1, 2016 Feb 28, 2017 10-Q 2018-04-05
Q4 2016 -$399K -$147K -$91.8K -166% Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-16
Q3 2016 -$307K -$78.5K +$126K +61.6% Jun 1, 2016 Aug 31, 2016 10-K 2017-12-08
Q2 2016 -$433K -$26.5K +$127K +82.8% Mar 1, 2016 May 31, 2016 10-Q 2017-07-17
Q1 2016 -$561K -$147K -$91.6K -165% Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-14
Q4 2015 -$469K -$55.3K +$72.4K +56.7% Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-17
Q3 2015 -$541K -$205K -$35.9K -21.3% Jun 1, 2015 Aug 31, 2015 10-K 2017-12-08
Q2 2015 -$505K -$154K -$98K -175% Mar 1, 2015 May 31, 2015 10-Q 2016-07-13
Q1 2015 -$407K -$55.3K -$23.2K -71.9% Dec 1, 2014 Feb 28, 2015 10-Q 2016-04-18
Q4 2014 -$384K -$128K -$114K -857% Sep 1, 2014 Nov 30, 2014 10-Q/A 2016-04-08
Q3 2014 -$270K -$169K -$137K -428% Jun 1, 2014 Aug 31, 2014 10-K 2016-01-07
Q2 2014 -$133K -$55.9K -$51.1K -1085% Mar 1, 2014 May 31, 2014 10-Q/A 2015-11-17
Q1 2014 -$82.2K -$32.2K -$27.6K -594% Dec 1, 2013 Feb 28, 2014 10-Q/A 2015-11-17
Q4 2013 -$54.6K -$13.3K +$1.8K +11.9% Sep 1, 2013 Nov 30, 2013 10-Q/A 2015-11-17
Q3 2013 -$56.4K -$31.9K -$46.4K -321% Jun 1, 2013 Aug 31, 2013 10-K/A 2015-10-23
Q2 2013 -$10K -$4.71K -$713 -17.8% Mar 1, 2013 May 31, 2013 10-Q/A 2014-07-15
Q1 2013 -$9.33K -$4.64K -$2.79K -151% Dec 1, 2012 Feb 28, 2013 10-Q 2014-04-01
Q4 2012 -$6.54K -$15.1K -$4.89K -47.8% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-14
Q3 2012 -$1.65K $14.4K +$11.1K +331% Jun 1, 2012 Aug 31, 2012 10-K 2013-11-29
Q2 2012 -$12.7K -$4K +$101K +96.2% Mar 1, 2012 May 31, 2012 10-Q 2013-07-15
Q1 2012 -$114K -$1.85K -$4.83K -162% Dec 1, 2011 Feb 29, 2012 10-Q 2012-04-13
Q4 2011 -$109K -$10.2K -$1.44K -16.3% Sep 1, 2011 Nov 30, 2011 10-Q 2013-01-14
Q3 2011 -$107K $3.35K Jun 1, 2011 Aug 31, 2011 10-K 2013-11-29
Q2 2011 -$105K Mar 1, 2011 May 31, 2011 10-Q 2012-07-06
Q1 2011 $2.98K Dec 1, 2010 Feb 28, 2011 10-Q 2012-04-13
Q4 2010 -$8.81K Sep 1, 2010 Nov 30, 2010 10-Q 2012-01-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.